Green Financial Statements From 2010 to 2025
| GRCU Stock | USD 0.0001 0.00 0.00% |
Check Green Cures financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Green Cures' main balance sheet or income statement drivers, such as , as well as many indicators such as . Green financial statements analysis is a perfect complement when working with Green Cures Valuation or Volatility modules.
Green |
Green Cures Botanical Company Profit Margin Analysis
Green Cures' Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Green Cures Profit Margin | 4.96 % |
Most of Green Cures' fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Green Cures Botanical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Green Cures Botanical has a Profit Margin of 4.9644%. This is 144.29% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The profit margin for all United States stocks is notably lower than that of the firm.
Green Cures Botanical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Green Cures's current stock value. Our valuation model uses many indicators to compare Green Cures value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Green Cures competition to find correlations between indicators driving Green Cures's intrinsic value. More Info.Green Cures Botanical is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers reporting about 0.04 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Green Cures Botanical is roughly 23.75 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Green Cures' earnings, one of the primary drivers of an investment's value.About Green Cures Financial Statements
Green Cures shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Green Cures investors may analyze each financial statement separately, they are all interrelated. The changes in Green Cures' assets and liabilities, for example, are also reflected in the revenues and expenses on on Green Cures' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Green Cures Botanical Distribution Inc. operates various services and products in the medical marijuana and botanical industry. Green Cures Botanical Distribution Inc. is based in Inglewood, California. Green Cures operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 20 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Green Pink Sheet Analysis
When running Green Cures' price analysis, check to measure Green Cures' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Green Cures is operating at the current time. Most of Green Cures' value examination focuses on studying past and present price action to predict the probability of Green Cures' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Green Cures' price. Additionally, you may evaluate how the addition of Green Cures to your portfolios can decrease your overall portfolio volatility.